Pluri (PLUR) Share-based Compensation (2010 - 2025)
Pluri (PLUR) posted quarterly Share-based Compensation of $857000.0 for Q4 2025, up 234.77% year-over-year from $256000.0 in Q4 2024, and up 1685.42% quarter-over-quarter from $48000.0 in Q3 2025.
Pluri (PLUR) Share-based Compensation (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Share-based Compensation for 16 consecutive years, with $857000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Share-based Compensation rose 234.77% year-over-year to $857000.0; the TTM figure through Dec 2025 stood at $2.2 million (up 10.43% YoY), while the FY2025 annual figure was $2.1 million, down 18.14% from the prior year.
- Share-based Compensation climbed to $857000.0 in Q4 2025 per PLUR's latest filing, from $48000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.5 million in Q1 2021 and bottomed at $48000.0 in Q3 2025.
- Historically, Share-based Compensation has averaged $1.4 million across 5 years, with a median of $885000.0 in 2022.
- Annual changes were most pronounced in 2021 — Share-based Compensation soared 8146.27% — and 2025, when it plunged 91.4%.
- Pluri's Share-based Compensation stood at $1.9 million in 2021, then tumbled by 51.25% to $913000.0 in 2022, then plunged by 37.24% to $573000.0 in 2023, then plunged by 55.32% to $256000.0 in 2024, then jumped by 234.77% to $857000.0 in 2025.
- Business Quant data shows PLUR's Share-based Compensation at $857000.0 in Q4 2025, $48000.0 in Q3 2025, and $838000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | Pluri | 16.11 Mn | 3.63 Mn | 86,000.00 | 857,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 857,000.00 |
| Dec 31, 2025 | 857,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Jun 30, 2025 | 838,000.00 |
| Jun 30, 2025 | 838,000.00 |
| Mar 31, 2025 | 491,000.00 |
| Mar 31, 2025 | 491,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Sep 30, 2024 | 558,000.00 |
| Sep 30, 2024 | 558,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | 618,000.00 |
| Mar 31, 2024 | 618,000.00 |
| Dec 31, 2023 | 573,000.00 |
| Dec 31, 2023 | 573,000.00 |
| Sep 30, 2023 | 836,000.00 |
| Sep 30, 2023 | 836,000.00 |